Rapid Micro Biosystems
Operations · MA, United States
Winning the race to bring new healthcare products safely to a waiting world drives Rapid Micro Biosystems (RMB) to combine today’s innovative technologies as never before. Your career at RMB puts you at the center of diverse global teams that span robotics, AI, Machine Learning, imaging, microbiology, and more, re-shaping how urgently needed pharmaceuticals are made, tested, and released for decades to come. The sky’s the limit.
Careers at RMB are fast-moving, with the high growth you’d expect from a world leader in microbiology automation. Advancement at RMB affords an opportunity to achieve your personal goals and develop your passions, in an inclusive environment where every employee has the resources and opportunities to hone their skills. You’ll do more, learn more, and have the ability to make a profound impact on our business.
The Manager of Total Rewards and HRIS supports our global business and plays a multifaceted role including ownership of the compensation, benefits and incentives programs and processes for the business (including supporting strategic compensation activities) and the organization’s HR systems/technology platforms (HRIS) in addition to day-to-day responsibilities. This hands-on role requires a blend of critical thinking and practical execution to ensure that these programs and systems are competitive, cost-effective, compliant with regulations and are aligned with the Company’s strategic goals to effectively attract, retain, and engage top talent. The Manager will work closely with the HR team as well as senior leadership and cross-functional teams including finance/accounting to optimize total rewards and HR systems/technology, aligning to support employee attraction, retention and the overall employee value proposition through a comprehensive total rewards framework.
Key Job Responsibilities:
Qualifications:
This job is not in any teams
This job is not in any offices
Rapid Micro Biosystems
1 followers
Rapid Micro Biosystems accelerates the detection of microbial contamination in the manufacture of pharmaceuticals, biologics, medical devices, and personal care products. The company’s Growth Direct™ Platform—the first and only growth-based platform to fully automate traditional microbial testing—detects contamination more quickly, delivering compelling economic benefits while improving quality control processes.